Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Deraco

Showing results (41-50 of 178) with videos related to

Pageof 18
Sort By:
Annals of Surgical Oncology|July 28, 2018
Dose-Dependent Effect of Red Blood Cells Transfusion on Perioperative and Long-Term Outcomes in Peritoneal Surface Malignancies Treated with Cytoreduction and HIPECEran Nizri, Shigeki Kusamura, Giuditta Fallabrino, et al.
Journal of Surgical Oncology|August 30, 2008
Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancerC William Helm, Robert E Bristow, Shigeki Kusamura, et al.
Annals of Surgical Oncology|November 7, 2019
Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS)Dario Baratti, Shigeki Kusamura, Norfarizan Azmi, et al.
Annals of Surgical Oncology|November 18, 2015
The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Shigeki Kusamura, Pilar Adriana Torres Mesa, Antonello Cabras, et al.
Critical Reviews in Oncology/Hematology|February 13, 2016
Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic reviewDario Baratti, Shigeki Kusamura, Filippo Pietrantonio, et al.
Annals of Surgical Oncology|November 8, 2023
Impact of Perioperative Systemic Chemotherapy on Survival for Patients Who have Diffuse Malignant Peritoneal Mesothelioma Treated with CRS-HIPECAmbarish Chatterjee, Shigeki Kusamura, Dario Baratti, et al.
European Journal of Cancer (Oxford, England : 1990)|July 9, 2013
Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)Dario Baratti, Shigeki Kusamura, Antonello Domenico Cabras, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2020
Comparative study of mucinous and non-mucinous appendiceal neoplasms with peritoneal dissemination treated by cyoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)Niharika Rajan Garach, Shigeki Kusamura, Marcello Guaglio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 19, 2023
Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Jorge Nogueiro, Nik Qisti Fathi, Marcello Guaglio, et al.
Annals of Surgery|May 15, 2012
Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapyDario Baratti, Shigeki Kusamura, Elvira Mingrone, et al.
Pageof 18

Showing results (41-50 of 178) with videos related to

Sort By:
Pageof 18
Annals of Surgical Oncology|July 28, 2018
Dose-Dependent Effect of Red Blood Cells Transfusion on Perioperative and Long-Term Outcomes in Peritoneal Surface Malignancies Treated with Cytoreduction and HIPECEran Nizri, Shigeki Kusamura, Giuditta Fallabrino, et al.
Journal of Surgical Oncology|August 30, 2008
Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancerC William Helm, Robert E Bristow, Shigeki Kusamura, et al.
Annals of Surgical Oncology|November 7, 2019
Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS)Dario Baratti, Shigeki Kusamura, Norfarizan Azmi, et al.
Annals of Surgical Oncology|November 18, 2015
The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Shigeki Kusamura, Pilar Adriana Torres Mesa, Antonello Cabras, et al.
Critical Reviews in Oncology/Hematology|February 13, 2016
Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic reviewDario Baratti, Shigeki Kusamura, Filippo Pietrantonio, et al.
Annals of Surgical Oncology|November 8, 2023
Impact of Perioperative Systemic Chemotherapy on Survival for Patients Who have Diffuse Malignant Peritoneal Mesothelioma Treated with CRS-HIPECAmbarish Chatterjee, Shigeki Kusamura, Dario Baratti, et al.
European Journal of Cancer (Oxford, England : 1990)|July 9, 2013
Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)Dario Baratti, Shigeki Kusamura, Antonello Domenico Cabras, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2020
Comparative study of mucinous and non-mucinous appendiceal neoplasms with peritoneal dissemination treated by cyoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)Niharika Rajan Garach, Shigeki Kusamura, Marcello Guaglio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 19, 2023
Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Jorge Nogueiro, Nik Qisti Fathi, Marcello Guaglio, et al.
Annals of Surgery|May 15, 2012
Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapyDario Baratti, Shigeki Kusamura, Elvira Mingrone, et al.
Pageof 18